Case number 1:21-cv-01172
Merck Sharp & Dohme Corp. v. MSN Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 7, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [14]. (nms) |
| Jan 7, 2022 | 13 | Proposed Consent Judgment (4) Docket Text: PROPOSED Consent Judgment as to Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 1/7/2022 (nms). |
| Jan 7, 2022 | 14 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT between Plaintiff and MSN Laboratories Private Limited, and MSN Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 1/7/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01172-RGA(nms) |
| Jan 7, 2022 | 15 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # (1) Consent Judgment)(nms) |
| Jan 7, 2022 | 15 | Consent Judgment (4) |
| Dec 20, 2021 | N/A | Order (0) Docket Text: SO ORDERED Granting (D.I. 12 in 21-cv-1172-RGA; D.I. 643 in 19-md-2902-RGA) Joint Status Report and Stipulation to Extend Time to January 20, 2022. Signed by Judge Richard G. Andrews on 12/20/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01172-RGA(nms) |
| Dec 20, 2021 | 12 | Status Report (3) Docket Text: Joint Status Report and Stipulation to Extend Time, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 12/20/2021 (nms). Modified on 12/20/2021 (nms). |
| Dec 15, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Defendants MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited answers were due to be filed on 12/13/2021, and to date none have been filed. Plaintiff is now requested to file a status letter within 3 days from the entry of this Order. Ordered by Judge Richard G. Andrews on 12/15/2021. Associated Cases: 1:21-cv-01172-RGA, 1:19-md-02902-RGA(nms) |
| Nov 23, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The status report and stipulation filed at D.I. 10 has been removed from the docket. The filing lacked reference in the case caption to the MDL case this relates to. Plaintiff shall correct the filing and refile the status/stipulation in both the MDL action as well as this one. (nms) |
| Nov 23, 2021 | N/A | Order (0) Docket Text: SO ORDERED Granting (D.I. 10 in 21-cv-1172-RGA; D.I. 628 in 19-md-2902-RGA) Stipulation to Extend Time to answer, move or otherwise respond to the complaint to December 13,2021. Signed by Judge Richard G. Andrews on 11/23/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01172-RGA(nms) |
| Nov 23, 2021 | 10 | Status Report (3) Docket Text: Joint Status Report and Stipulation to Extend Time, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/23/2021 (nms). |
| Nov 19, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Answers were due to be filed on 11/12/2021 (see D.I. [7] and D.I. [8]), and to date none have been filed. Plaintiff is now requested to file a status letter within 3 days from the entry of this Order. Ordered by Judge Richard G. Andrews on 11/19/2021. (nms) |
| Sep 17, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For MSN Laboratories Private Limited waiver sent on 9/13/2021, answer due 11/12/2021. (Joyce, Alexandra) |
| Sep 17, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For MSN Pharmaceuticals Inc. waiver sent on 9/13/2021, answer due 11/12/2021. (Joyce, Alexandra) |
| Sep 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (185 in 19-cv-319-RGA; 73 in 20-cv-815-RGA; 12 in 21-cv-824-RGA; 48 in 20-cv-1496-RGA; 156 in 19-cv-314-RGA; 572 in 19-md-2902-RGA; 104 in 20-cv-949-RGA; 6 in 21-cv-1172-RGA; 91 in 20-cv-847-RGA; 114 in 20-cv-749-RGA; 35 in 21-cv-315-RGA; 109 in 20-cv-1099-RGA; 167 in 19-cv-312-RGA; 8 in 21-cv-1173-RGA; 177 in 19-cv-313-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/8/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Sep 8, 2021 | 6 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for David M. Krinsky)(Silver, Daniel) |
| Sep 8, 2021 | 6 | Certification for David M. Krinsky (1) |
| Aug 18, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:21-cv-01172-RGA, 1:21-cv-01173-RGA (rjb) |
| Aug 12, 2021 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (twk) |
| Aug 12, 2021 | 1 | Main Document (16) Docket Text: COMPLAINT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3677733.) - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(twk) |
| Aug 12, 2021 | 1 | Exhibit A (18) |
| Aug 12, 2021 | 1 | Civil Cover Sheet (3) |
| Aug 12, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Aug 12, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than June 30, 2021. Date of Expiration of Patent: November 24, 2026 (May 24, 2027 pediatric exclusivity expiration). Thirty Month Stay Deadline: No Earlier than 12/30/2023. (twk) |
| Aug 12, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (twk) |
| Aug 12, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (twk) |
| Aug 12, 2021 | 1 | Complaint* (1) |
